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Regulated cell death is essential in development and cellular homeostasis. Multi-protein
platforms, including the Death-Inducing Signaling Complex (DISC), co-ordinate cell fate via a
core FADD:Caspase-8 complex and its regulatory partners, such as the cell death inhibitor c-
FLIP. Here, using electron microscopy, we visualize full-length procaspase-8 in complex with
FADD. Our structural analysis now reveals how the FADD-nucleated tandem death effector
domain (tDED) helical filament is required to orientate the procaspase-8 catalytic domains,
enabling their activation via anti-parallel dimerization. Strikingly, recruitment of c-FLIPS into
this complex inhibits Caspase-8 activity by altering tDED triple helix architecture, resulting in
steric hindrance of the canonical tDED Type I binding site. This prevents both Caspase-8
catalytic domain assembly and tDED helical filament elongation. Our findings reveal how the
plasticity, composition and architecture of the core FADD:Caspase-8 complex critically
defines life/death decisions not only via the DISC, but across multiple key signaling platforms
including TNF complex II, the ripoptosome, and RIPK1/RIPK3 necrosome.
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Regulated cell death is essential in development and cellularhomeostasis. Aberrant levels or inappropriate initiation ofcell death can result in cancer, auto-immune disorders and
neurodegenerative disease. Cell death proceeds via different
pathways depending on the stimulus and the subsequent protein
complexes that are formed. Caspase-8 and FADD are core
components of the canonical death-inducing signaling complex
(DISC), which is formed when the extrinsic apoptosis pathway is
triggered via binding of ligand to death receptors (DRs) of the
tumor necrosis factor (TNF) receptor (TNFR) superfamily, e.g.,
TRAIL-R1/R2 or CD95. Ligand binding induces clustering of
DRs, enabling recruitment of the adapter protein FADD via its
death domain (DD) to the intracellular DDs of oligomerized DRs.
Procaspase-8 (defined as full-length Caspase-8 monomer) then
binds to FADD via death effector domain (DED) interactions,
thereby forming the DISC. FADD and Caspase-8 are not only
key proteins of the canonical CD95/TRAIL-R DISC, but are also
core components of the cytosolic TNF complex II1,2, the
ripoptosome3,4 as well as RIPK1/RIPK3-containing necroptotic
complexes5. In all these scenarios, DED-mediated interaction
between FADD and Caspase-8 is critical for cell death induction6.
Thus, uncovering the molecular architecture of the core FADD:
Caspase-8 complex, and how this is affected by interaction with
other regulatory partners is essential for understanding how cell
death is regulated.
Extensive biochemical characterization of the native CD95/
TRAIL DISC isolated from cells revealed that FADD was present
at sub-stoichiometric levels compared to both DRs and Caspase-
87,8. These studies suggested that following ligand-induced DR
oligomerization and DD-mediated FADD recruitment9–11,
FADD undergoes a conformational change that enables recruit-
ment of multiple Caspase-8 molecules. This led to the proposal of
the DED chain model in which Caspase-8 proteins interact
sequentially via their tandem DEDs (tDEDs). The proposed
helical chain of Caspase-8 molecules, nucleated by a single FADD
molecule, is able to form via the interaction of a canonical ‘FL
motif’ on one Caspase-8 DED2 into the DED1 pocket region on
the adjacent Caspase-87. This protein–protein interaction has
subsequently been named a Type I interaction12. These DED
chains or ‘death effector filaments’ have also been visualized by
confocal microscopy by expressing GFP-labeled Caspase-8
tDEDs-only7,13. Subsequent Cryo-Electron Microscopy (Cryo-
EM) studies of the tDED-only filament revealed that, rather than
being a single strand of tDED molecules, filaments are made up of
three tDED strands which wind around each other to form a
triple helix structure12.
Early biochemical studies showed that procaspase-8 exists as a
monomer and enzymatic activation requires dimerization of the
catalytic domains of two Caspase-8 molecules, each made up of a
large (p18) and small (p10) subunit14–16. On dimerization, a
series of auto-cleavage events occur at key aspartic acid residues,
resulting in removal of the inter-domain linker between the large
and small subunits16,17. Structural determination of the fold of
the cleaved catalytic domains showed that the two catalytic
domains must associate in an anti-parallel orientation relative to
each other14,15,18. This interaction is thought to result in mod-
ifications to the tertiary structure that facilitate formation of the
substrate binding and catalytic sites of the Caspase-8 dimer.
Importantly, both dimerization and auto-processing of the cata-
lytic domains of procaspase-8 are required to produce an active
protein capable of driving apoptosis19,20. To date, structural
information on the catalytically inactive Caspase-8 p18-p10
monomer is solely based on NMR analysis of a truncated (ΔDED)
recombinant Caspase-8. This revealed that the inter-domain
linker between the large and small subunits blocks the active
site21, rendering the Caspase-8 monomer catalytically inactive.
However, there is an important caveat to the interpretation of
these studies, namely that all the data are for truncated recom-
binant Caspase-8 lacking the tDEDs at the N-terminus of the
natural protein.
Thus, although there has been a concerted effort to determine
the structure of the individual proteins and the overall architecture
of the DISC, to date, all published structures have been of indi-
vidual/truncated domains of isolated recombinant proteins9–11.
Often mutations have also been introduced to facilitate expression
of high concentrations of soluble proteins amenable to structural
determination by X-ray crystallography12,14,15,18,22,23 or NMR21.
Since procaspase-8 recruitment to the DISC (and other FADD-
based signaling platforms) is mediated via FADD-nucleated tDED
interactions, these studies cannot predict the effect of tDEDs on
structural dimerization/activation of procaspase-8. Moreover, the
impact of recruitment of other tDED proteins including known
regulators of FADD:Caspase-8 signaling complexes e.g., c-FLIP
isoforms/Caspase-10, on tDED filament architecture/procaspase-
8 signaling outcome has not been explored.
Furthermore, it remains unknown how the proposed tDED-
only filament structure facilitates Caspase-8 catalytic domain
dimerization/activation. In this study, we have solved this con-
undrum by co-expressing soluble full-length procaspase-8 toge-
ther with FADD. Using electron microscopy we now visualize the
structural architecture of the FADD-nucleated full-length
Caspase-8 complex. Crucially, our data explain how the triple
helix tDED filament structure facilitates dimerization and acti-
vation of procaspase-8. Furthermore, by incorporation of c-FLIPS
into the complex, we provide a structural explanation as to how c-
FLIPS both terminates tDED filament assembly and inhibits
Caspase-8 activation. Thus, by visualizing and determining the
structure of the core FADD:Caspase-8 activation complex, we
provide insights into cell death regulation, not only by the DISC
but also across similar FADD:Caspase-8 signaling platforms that
co-ordinate cell fate.
Results
Full-length Caspase-8 filament formation is nucleated by
FADD. To investigate the molecular architecture of FADD:
Caspase-8 complexes (Fig. 1a), FLAG-tagged FADD and full-
length catalytically inactive Caspase-8 (C360A; hereafter referred
to as Caspase-8) were co-expressed in HEK 293F cells (Caspase-
8-null 293F, clone 1D3; Supplementary Fig. 1) and the resultant
soluble complexes isolated using FLAG affinity resin. Complexes
were eluted from the beads and purified using glycerol density
gradient centrifugation. Analysis of the purified gradient frac-
tions revealed a heterogeneous mixture of complexes spread over
12 fractions (Fig. 1b). Most of the complexes eluted in fractions
7-13 where both FADD and Caspase-8 could be detected by
Western blotting. Analysis of complexes in selected fractions
across the gradient by negative-stain transmission electron
microscopy (EM) showed that the complexes were filament-like
in shape and increased in length across the gradient (Fig. 1c and
Supplementary Fig. 2). Furthermore, analysis of the stoichio-
metry of FADD and Caspase-8 in the different gradient fractions
by quantitative label-free LC-MS/MS revealed increasing
amounts of Caspase-8, relative to FADD as the complexes
increased in length (Fig. 1d).
We next investigated the composition of these FLAG-FADD:
Caspase-8 complexes using Immuno-gold labeling of the
component proteins (Fig. 1e and Supplementary Fig. 3). Com-
plexes were labeled with either anti-FLAG to determine the
position of FADD or with anti-Caspase-8. Anti-FLAG labeling
revealed a single gold moiety positioned at one end of the
complex, whereas anti-Caspase-8 labeling resulted in multiple
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Fig. 1 Caspase-8 filament formation is nucleated by FADD. a Schematic representation of the architecture of DISC. b Western blot analysis of Glycerol
Density Gradient purification of soluble Flag-FADD:Caspase-8 complexes. Western blots are representative of 3 independent experiments. c Negative-
stain EM of FADD:Caspase-8 filaments purified from different gradient fractions (Fractions 10, 13 and 15). Micrographs are representative of 3 independent
experiments. d Label-free quantitative mass spectrometry determination of FADD:Caspase-8 ratio in Glycerol Density Gradient fractions (Graph shows
Mean ± SD, n= 3 technical repeats; from a representative experiment of 3 biologically independent experiments). e Immuno-gold labeling of FLAG-tag and
Caspase-8 p18 subunit in purified filament complexes from Fraction 10 within the peak visualized by EM. Micrographs are representative of 3 independent
experiments. f Structural model of FADD:Caspase-8 tDED single-chain complex. Source data are provided as a Source Data file.
NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-020-20806-9 ARTICLE
NATURE COMMUNICATIONS |          (2021) 12:819 | https://doi.org/10.1038/s41467-020-20806-9 | www.nature.com/naturecommunications 3
gold moieties detected along the filament. These results
demonstrate that full-length Caspase-8 forms complexes that
are nucleated by FADD, which extend their filament length by the
addition of an increasing number of Caspase-8 molecules
(Fig. 1f).
Negative-stain EM structure determination of FADD:Caspase-
8 filament. Negative-stain EM data of FLAG-FADD:Caspase-8
complexes, collected from Fraction 10 within the peak of the
density gradient (Fig. 1b), provided sufficiently homogeneous
complexes for structural determination. Filaments of similar
lengths were picked using a mask of maximal length 700 Å and
reference-free 2D class averages generated in RELION using the
single-particle approach (Fig. 2a and Supplementary Figs. 4–6).
While some 2D classes were different lengths, there was clearly a
lower level of density in the center of each filament suggesting the
core complex could be a tubular structure. Furthermore, many of
the filaments were decorated with extra density which we hypo-
thesized may be the presence of the catalytic domains of full-
length Caspase-8. An initial low-resolution 3D model of the data
was generated in CryoSPARC (Fig. 2b). This map (Supplemen-
tary Fig. 7) had stronger density near the center of the recon-
struction and substantially weakened density at the periphery.
This density gradient is most likely due to a combination of: (i)
compositional heterogeneity near the ends of the filaments; (ii)
conformational flexibility of the individual particles that are used
in the reconstruction; (iii) uncertainty in the angular alignment of
the particles. These elements will show stronger effects at the edge
than at the center of the reconstruction. We further refined the
3D model with various masked sub-volumes of the EM map and
then refined these separately. This procedure revealed that the
two ends of the complex were different (Supplementary Fig. 8),
with one end exhibiting an open helical-shaped configuration. We
have named this the ‘extending’ end (Supplementary Fig. 9), and
hypothesize this is where additional Caspase-8 molecules would
bind to extend the filament. In contrast, the other end of the
complex displayed a closed tapered appearance (Fig. 2b), which
we propose is the ‘initiating’ end of the filament where FADD is
positioned. 3D refinement of the central region (Fig. 2b and
Supplementary Fig. 7) revealed that the central filament structure
was indeed a hollow tubular structure. However, additional dis-
creet EM volumes were attached periodically to the exterior,
suggesting that these may map to the catalytic domains of
Caspase-8.
To determine if the discreet EM volume decorating the exterior
of the filament structure was indeed the p18-p10 catalytic
domains of Caspase-8, the tDEDs of Caspase-8 without catalytic
domains were expressed. The FADD-nucleated Caspase-8 tDED
complexes were again purified using glycerol density gradient
centrifugation (Fig. 2c) and negative-stain EM data collected.
Complexes, of the same length as full-length Caspase-8
complexes, were analyzed in CryoSPARC. The resultant
reference-free 2D class averages (Fig. 2d) were filamentous in
shape and exhibited a lower central EM density, similar to that
previously observed in full-length Caspase-8 complexes (Fig. 2a).
A low-resolution 3D model generated in CryoSPARC (Fig. 2e;
mesh) revealed a smooth tube-shaped EM volume. Importantly,
overlaying this tDED-only filament volume onto the central
region of the full-length Caspase-8 3D map, confirmed that the
core central filament structure is composed of Caspase-8 tDEDs
while the additional EM volume decorating the full-length
Caspase-8 model most likely represents the catalytic domains
(Fig. 2e).
To determine the core structure of the FADD-nucleated full-
length Caspase-8 activation complex, the published structure of
the tDEDs alone (5L08,12) was fitted as a rigid body into the EM
volume of the FADD:full-length Caspase-8 (Fig. 3a). The
published tDED-only structure is made up of three tDED strands
in a triple helix, where each strand is consistent with the tDED-
based helical model proposed by Dickens et al.7 (Supplementary
Fig. 10). tDEDs in Strands 1 (blue) and 2 (green) are rotated ~20˚
along the axis of the filament relative to each other, resulting in
the DED2 domains being “aligned” with their carboxy termini
within 35 Å of each other. The DED2 domains on Strand 3 (cyan)
however, are rotated ~70˚ relative to Strand 1 so the carboxy
termini are further apart (~50 Å); we, therefore, term this the
“offset” strand (Supplementary Fig. 11). Importantly, this
structure fits well within the tubular-shaped core EM volume
(Fig. 3a); furthermore, we observed that all complexes formed
were of a uniform width suggesting that all three tDED strands
extend simultaneously.
We then investigated if/how this tDED triple helix filament
structure could facilitate Caspase-8 catalytic domain activation.
NMR-based structural determination of monomeric Caspase-8
catalytic domains revealed that the inter-domain linker between
the large (p18) and small (p10) catalytic subunits blocks the active
site, rendering the Caspase-8 monomer inactive21 (Fig. 3b). Upon
dimerization, a series of auto-cleavage events occur at key aspartic
acid residues, resulting in removal of the inter-domain linker14
(Fig. 3b). The two catalytic domains within the dimer then
associate in an anti-parallel orientation relative to each other16
(Fig. 3c). This anti-parallel orientation is crucial for formation of
the substrate binding/catalytic sites of the Caspase-8 dimer. In
our study full-length catalytically inactive (C360A) was expressed,
therefore we modeled an uncleaved Caspase-8 catalytic domain
dimer (Fig. 3b, based on 2k7z;21) to fit as a rigid body into the
model of the FADD:full-length Caspase-8 EM volume (Fig. 3d).
Importantly, this structure fits well within the EM volume we had
hypothesized to be the catalytic domains within the Caspase-8
EM volume (Fig. 2e).
Investigation of the relative spatial orientations of the known
structures fitted into the EM volume (Fig. 3e), revealed how the
tDED filament of Caspase-8 facilitates anti-parallel dimerization
of the catalytic domains. Thus, the dimerized catalytic subunits
originate from Caspase-8 tDEDs that reside on different, but
aligned strands (labeled Strands 1 (blue) and 2 (green)) within the
tDED triple helix (Fig. 3e). At this resolution, there is no
identifiable EM volume for the flexible linker that connects the
tDED and p18 catalytic subunit of full-length Caspase-8.
However, in our model the positioning of the second Caspase-8
catalytic dimer is such that its corresponding tDEDs also reside
on the aligned Strands 1 and 2 within the triple helix (Fig. 3e).
tDED helical filament architecture is essential for activation of
Caspase-8. As the tDED helical filament consists of 3 strands12,
and having established that Caspase-8 catalytic subunit dimers
originate from Caspase-8 molecules residing on adjacent strands
(Fig. 3e, Strands 1 and 2), we wished to determine the significance
of both intra- and inter-strand interactions within the FADD:
Caspase-8 complex architecture and their effect on Caspase-8
activation. Type I contacts occur within a single strand (intra-
strand) between the canonical FL motif on DED2 and adjacent
pocket residues on DED1 of the next Caspase-8 molecule, and are
essential for Caspase-8 activity7,24 (Fig. 4a, schematic). By con-
trast, the interactions identified by Cryo-EM in the Caspase-8
tDED-only structure describe tDED inter-strand contacts termed
Type II and III interactions12 (Fig. 4a, schematic). Mutation of
the intra-strand Caspase-8 Type I contact F122G/L123G resulted
in a significant shift in the buoyant density (size) of the FLAG-
FADD:Caspase-8 complexes purified by density gradient
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Fig. 2 Negative-stain EM model of FADD:full-length Caspase-8 filament. a Reference-free 2D class averages generated in RELION of negative-stain EM
of FLAG-FADD:Caspase-8 complexes. b Initial model generated in CryoSPARC. Whole filament shown in blue (27 Å) with views of ‘closed’ initiating
end (left) and ‘open’ extending end (right). Gray EM volumes are refinements of masked sections of the full filament; both the initiating end (17 Å)
and central Caspase-8 only region of complex (14.5 Å). cWestern blot analysis of Glycerol Density Gradient purification of soluble FADD:Caspase-8 tDED-
only (expressed together with FLAG-c-FLIPS to stabilize the tDED-only complexes). Western blots are representative of 3 independent experiments.
d Reference-free 2D class averages generated in CryoSPARC of negative-stain EM of FADD:Caspase-8 tDED-only complexes. e Overlay of initial model
generated in CryoSPARC of central region of Caspase-8 tDED-only complex (mesh) with EM volume of central region of full-length Caspase-8 filament.
Source data are provided as a Source Data file.
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Fig. 3 Core tDED triple-helix facilitates inter-strand Caspase-8 catalytic domain anti-parallel dimerization. Refined central region of full-length Caspase-
8 filament with, a published tDED-only structure (5L08;12) fitted as a rigid body. b Ribbon NMR-based structural model of dimerized uncleaved catalytic
subunit domains (2k7z; 21; upper panel, C360A in red and K224 as filled circle) and ribbon X-ray structure of cleaved catalytic subunit dimer (3KJQ;14;
lower panel). c Schematic representation of uncleaved Caspase-8 p18 (large) and p10 (small) catalytic domains in anti-parallel orientation relative to tDED
domains. d Fitted ribbon diagram of Caspase-8 tDEDs and catalytic domain assembly. Each strand of the helix is coloured; blue and green strands contain
aligned DEDs, while in the cyan strand the DEDs are offset. e Caspase-8 catalytic domain subunit colours reflect the DED strand from which they originate.
Distance between the termini connected by the dashed lines is approximately 35 Å, which can be accommodated by the 32 amino acid flexible linker
between the tDED and catalytic domains of Caspase-8.
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centrifugation (Fig. 4a). There was a marked decrease in the
amount of protein filament complexes, as the majority of
expressed proteins eluted in fractions where uncomplexed FLAG-
FADD normally sediments. Importantly, TEM analysis and
quantitation of the Type I mutant complexes in Fraction 10,
showed fewer complexes compared to FLAG-FADD:Caspase-8
and they appeared to be globular aggregates rather than filaments
(Fig. 4b and Supplementary Fig. 12). Mutation of residues R52
(Type II), K148/R149 (Type II) and D15 (Type III), all of which
were identified as being involved in inter-strand contacts, pro-
duced contrasting results. The R52E mutant sedimented as a
tighter peak (over 7 fractions) and contained a mixture of slightly
thinner filaments and fragmented globular structures (Fig. 4a,b
and Supplementary Fig. 12). Mutation of K148D/R149E resulted
in a significant proportion of uncomplexed protein sedimenting
essentially as monomeric proteins and a reduced number of
complexes, which were shorter in length than FLAG-FADD:
Caspase-8 filaments (Fig. 4b, compare Caspase-8 with contact
mutants). The D15R mutation produced fewer complexes, which
sedimented similarly to FADD:Caspase-8 complexes and on TEM
appeared as shortened filaments (Fig. 4b and Supplementary
Fig. 12). Thus, the most notable mutation which affected the
FADD:Caspase-8 structure as visualized/quantified by TEM was
mutation of the canonical Type I contact, which completely
abrogated filament formation. However, mutation of the inter-
strand contacts (Type II and III) resulted in abnormal filament
structures of variable size and shape.
A key question is how does abnormal filament shape and size
impact on Caspase-8 catalytic domain dimerization and sub-
sequent enzymic activation. We tested this using a functional
reconstituted CD95 DISC (r-DISC) model which, as described
previously19, uses GST-tagged CD95 intracellular domain (CD95-
IcD) complexed with recombinant FADD (r-FADD) to form a
nucleating scaffold that recruits/activates recombinant
procaspase-8. In this r-DISC model, wild-type procaspase-8 is
recruited to the r-DISC, auto-catalytically cleaved to its signature
cleavage products and Caspase-8 proteolytic activity determined
by cleavage of the fluorogenic substrate Ac-IETD.AFC (IETDase
activity; Fig. 4c). Mutation of the catalytic site (C360A) did not
block procaspase-8 recruitment but autocatalytic inter-domain
cleavage and IETDase activity were inhibited (Fig. 4c). Addition-
ally, F122G/L123G (Type I), D15R (Type III) and K148D/R149E
(Type II in DED2) mutations markedly reduced procaspase-8
incorporation to the r-DISC and completely blocked generation
of cleavage fragments and IETDase activity (Fig. 4c, Lanes 3, 4 &
6). The R52E mutant (Type II in DED1) was recruited to the r-
DISC, but was only marginally active as judged by generation of
cleavage fragments and IETDase activity which was less than a
third of the activity observed with wild-type Caspase-8 (Fig. 4c,
Lane 5). Thus, mutation of the canonical Type I interaction
mediated via the FL motif not only blocks filament formation but
also totally prevents Caspase-8 activation. Disruption of contacts
that play a role in inter-strand interactions (Type II and III) also
clearly influence tDED helical filament architecture. We earlier
determined that catalytic domains from the aligned Strands 1 and
2 within the triple helix dimerize, thus disruption of the helical
architecture markedly abrogates formation of the Caspase-8
catalytic dimer active site and enzymic activation. To extend this,
we assessed the ability of Caspase-8 Type 1, II and III contact
mutants to rescue CD95-induced cell death in Caspase-8-
deficient Jurkat cells (Supplementary Fig. 13). Importantly, in
Jurkat T cells which are termed ‘Type 2 cells’ as they additionally
rely on mitochondrial amplification to successfully execute
apoptotic cell death25, only wild-type Caspase-8 was able to
rescue CD95-induced apoptosis. Thus, although the Caspase-8
R52 mutant had retained albeit low levels of caspase activity in a
pure reconstituted CD95 DISC (Fig. 4c), this low level DISC
activity alone is not sufficient to drive CD95-induced cell death in
‘Type 2 cells’.
c-FLIPS alters the architecture of the FADD:Caspase-8 complex
thereby preventing Caspase-8 filament elongation. Various
tDED-containing proteins are known to bind to FADD:Caspase-8
complexes and thereby modulate Caspase-8 activity (reviewed
in6). One of the best characterized of these is c-FLIP which
predominantly exists as two isoforms, c-FLIPL and c-FLIPS. c-
FLIPS functions as a key inhibitor of Caspase-8 activation in
several FADD:Caspase-8 signaling platforms, including the DISC,
ripoptosome and necrosome3,4,24. The mechanism whereby c-
FLIPS disrupts Caspase-8 activation is unknown; we therefore
wished to determine the effect of c-FLIPS on the architecture of
the FADD:Caspase-8 complex to uncover how c-FLIPS inhibits
Caspase-8 activity. To ensure the complexes examined all con-
tained c-FLIPS, we transiently co-expressed FLAG-tagged c-FLIPS
with untagged full-length FADD and full-length Caspase-8 using
a FADD:Caspase-8:FLAG-c-FLIPS ratio of 1:3:6. This generated
c-FLIPS-containing FADD:Caspase-8 complexes which were
affinity purified using FLAG affinity resin, eluted and further
purified using glycerol density gradient centrifugation. Analysis of
the gradient fractions revealed that the addition of c-FLIPS
resulted in complexes which equilibrated in lower density frac-
tions towards the top of the gradient, indicating they were smaller
(Fig. 5a) than the FADD:Caspase-8 filaments (Fig. 1b). Consistent
with this, analysis of the complexes by negative-stain EM revealed
that the FADD:Caspase-8:FLAG-c-FLIPS complexes were shorter
and more globular (Fig. 5b) than the FADD:Caspase-8 complexes
(Fig. 1c). Immuno-gold labeling of Caspase-8 in the FADD:Cas-
pase-8:FLAG-c-FLIPS complexes suggests that short filaments are
formed with multiple Caspase-8 proteins (Fig. 5c). Unlike Cas-
pase-8, c-FLIPS was positioned at one or both ends of the com-
plex (Fig. 5c). Importantly, this suggests that once c-FLIPS is
recruited into the complex further Caspase-8 molecules do not
bind.
Reference-free 2D class averages of the negative-stain com-
plexes (Fig. 5d and Supplementary Fig. 14) revealed that a
Caspase-8 filament begins to extend with similar characteristics to
that observed previously when Caspase-8 was co-expressed with
FADD alone (compare Fig. 5d with Fig. 2a). In addition, some
extra density is clearly visible along the filament reminiscent of
what we have shown previously in the FLAG-FADD:Caspase-8
complex to be the catalytic domains of Caspase-8. Interestingly,
with these smaller complexes, there are clear end-views of the
complex visible down the length of the filament. These views were
used to generate an initial low-resolution 3D model of the FADD:
Caspase-8:FLAG-c-FLIPS complex (Fig. 5e and Supplementary
Fig. 15). Comparison of the negative-stain EM volumes of FADD:
Caspase-8:FLAG-c-FLIPS and FLAG-FADD:Caspase-8 (Fig. 2b),
clearly shows that the presence of c-FLIPS in the complex
prevents tDED helical filament extension resulting in a shortened
complex (Fig. 5f). Moreover, in the presence of c-FLIPS, the
additional EM volume normally occupied by the catalytic
domains of Caspase-8 is reduced and its overall architecture
appears to be different (Fig. 5f, yellow region).
c-FLIPs blocks Caspase-8 filament elongation by steric hin-
drance of the canonical tandem DED binding site. We have
previously shown that c-FLIPS recruitment to FADD:Caspase-8
complexes is primarily mediated via co-operative binding of c-
FLIPL/S to Caspase-824. In the case of c-FLIPS, this results in
complete inhibition of Caspase-8 activity. The negative-stain EM
data established that the presence of c-FLIPS in the FADD:
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Fig. 4 tDED filament architecture is essential for Caspase-8 catalytic activity. a Left Panel, Schematics illustrate the position of Caspase-8 tDED Type I, II
and III interaction mutants within triple helix filament. Right Panel, Western blot analysis of Glycerol Density Gradient profiles of full-length Caspase-8
C360A (Caspase-8) and full-length Caspase-8 tDED interaction mutants. Western blots are representative of 3 independent experiments. b Negative-stain
EM of FADD in complex with full-length Caspase-8 C360A (Caspase-8) or Caspase-8 tDED interaction mutants. Representative filaments visualized are
from equivalent gradient fractions (Fraction 10), for each complex. Micrographs are representative of 3 independent experiments. c Reconstituted CD95
DISC (r-DISC; GST-CD95-IcD:r-FADD:r-Casp-8), assembled with Wt (Wild-type) or mutant 35S r-Casp-8b. Beads were analyzed for r-Casp-8b cleavage
and IETDase activity. Data shown are from one experiment, representative of 3 independent experiments. Source data are provided as a Source Data file.
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Fig. 5 c-FLIP short (c-FLIPS) prevents Caspase-8 filament elongation altering the architecture of the complex. a Western blot of Glycerol Density
Gradient profiles of FADD:full-length Caspase-8:FLAG-c-FLIPS complexes. Western blots are representative of 3 independent experiments. b Representative
negative stain micrograph of FADD:full-length Caspase-8:FLAG-c-FLIPS complexes (Scale bar, 100 nm; inset, 25 nm). Micrographs are representative of 3
independent experiments. c Immuno-gold labeling of p18 subunit of Caspase-8 and FLAG-tag on purified FADD:full-length Caspase-8:FLAG-c-FLIPS complexes
(Fraction 6), visualized by EM. Micrographs are representative of 3 independent experiments. d Reference-free 2D class averages generated in CryoSPARC of
negative-stain EM of FADD:full-length Caspase-8:FLAG-c-FLIPS complexes. e Different orientations of low-resolution EM volume of FADD:full-length Caspase-8:
FLAG-c-FLIPS complexes; side-view (left) and end-view (right). f Overlay comparison of FADD:full-length Caspase-8:FLAG-c-FLIPS complex negative-stain EM
volume and FADD:full-length Caspase-8 complex EM volume; additional EM volume only present in c-FLIPS-inhibited complex is shown in yellow. Source data
are provided as a Source Data file.
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Caspase-8 complex prevents tDED filament extension resulting in
a shortened complex (Fig. 5f). We next sought to obtain struc-
tural insight into how c-FLIPS interacts with Caspase-8. Through
analysis of the predicted fold of c-FLIPS from the protein
sequence, we identified key differences between the tDED
domains of c-FLIPS and Caspase-8 (Fig. 6a). Caspase-8:Caspase-8
filament elongation relies on the canonical ‘Type I’ tDED inter-
action between DED2 F122/L123 motif and the Y8 pocket on
DED1 (Fig. 6a, part i). However, when this interaction is modeled
for Caspase-8:c-FLIPS, it results in steric clashes between
Caspase-8 DED2 and c-FLIPS DED1 (Fig. 6a, part ii), suggesting
an alternative ‘non-canonical’ interface is involved. Using
HADDOCK (High Ambiguity Driven protein-protein DOCKing;
Webserver: haddock.science.uci.nl, Supplementary Fig. 16), we
identified a potential non-canonical binding orientation for
Caspase-8:c-FLIPS which, in addition to the canonical H7 pocket
residue, involves residue R38 of DED1 in c-FLIPS (Fig. 6a, part
iii). Using the r-DISC model, we tested the effect of mutating
these residues (Fig. 6b). When compared to WT c-FLIPS, the
individual c-FLIPS mutants, H7D and R38D, retained their ability
to bind to Caspase-8. However, with the double mutant H7D/
R38D, c-FLIPS binding to Caspase-8 was abolished, confirming
that both residues are involved in the DED binding interface
between Caspase-8 and c-FLIPS. Consequently, binding of c-
FLIPS to Caspase-8 via this non-canonical interaction motif alters
the orientation of the FL motif on DED2 of c-FLIPS. As a result,
c-FLIPS DED2 FL motif would not adopt the canonical orienta-
tion of Caspase-8 DED2 FL motif in a Caspase-8:Caspase-8
filament (Fig. 6c). This suggests that c-FLIPS likely alters the
overall topology of c-FLIPS-containing Caspase-8 complexes.
To further resolve the c-FLIPS interaction with Caspase-8
within the FADD:Caspase-8 complex, we collected a Cryo-EM
data set on the FADD:Caspase-8:FLAG-c-FLIPS complex (Sup-
plementary Figs. 17–20). Using a mask of 240 Å, complexes were
picked using CrYOLO26 to generate templates for automatic
picking in RELION327. 2D reference-free class averages were then
generated in RELION3 (Fig. 6d) and Cryo-EM 3D reconstruction
resulted in a 13 Å EM map (Fig. 6e). We fitted the known protein
structures into this map, choosing the hand of the envelope that
gave the best fit. Further validation of our 3D reconstruction by
tilt-pair analysis, however, was not possible due to the low signal-
to-noise ratio in our raw data. Using tDED interactions from the
Cryo-EM structure of tDEDs alone (5L08;12) and our threaded
structure of c-FLIPS orientated relative to Caspase-8 via our
predicted non-canonical binding interface (H7/R38), the EM
volume accommodates a short Caspase-8 triple helix filament
with c-FLIPS bound in the predicted binding site (Fig. 6f). This
further strengthens our finding that c-FLIPS binding to Caspase-8
occurs via a non-canonical interface. Moreover, the refined EM
map shows that when c-FLIPS is bound to the next available
tDED (green strand) within the Caspase-8 filament, the next
Caspase-8 molecule is not recruited to the adjacent aligned strand
(blue) as there is no volume present in the reconstructed EM map
of the complex (Fig. 6f, lower panel). It appears that Caspase-8
recruitment is inhibited at this site due to steric hindrance, as c-
FLIPS DED2 occupies the space where the next Caspase-8
molecule would bind on the adjacent strand of the filament
(Fig. 6g). Thus, binding of c-FLIPS abrogates chain elongation of
the neighboring strand, preventing long filament formation.
Binding of c-FLIPS prevents Caspase-8 catalytic domain
dimerization. The Caspase-8 tDED filament (5L08;12) and our
threaded c-FLIPS structures populate the lower areas of the
refined 3D EM map (Fig. 6f), however there is additional volume
at the top of the map that could accommodate the catalytic
domains of Caspase-8. These form narrow repeating volumes
along the top of the map with local resolution estimates (calcu-
lated in RELION), indicating they are some of the best aligned
features in the map (Fig. 7a). Due to the shape of these empty
areas of EM volume it was clear that the catalytic domains were
not in their active dimeric conformation as observed previously in
the FLAG-FADD:Caspase-8 complex (Fig. 3). Rather, the cata-
lytic domains appear to be monomeric, with the p18/p10 subunits
positioned too far apart to allow dimerization (Fig. 7b,c). The
positioning of the catalytic domains in the EM map in this ‘open
conformation’ rather than in the dimeric antiparallel ‘active state’
now provides a mechanism to explain how c-FLIPS inhibits the
catalytic activity of Caspase-8.
Discussion
Caspase-8 and FADD are key components of several multi-
protein complexes that co-ordinate cell fate, including the cano-
nical apoptosis-inducing DISC, the ripoptosome and
necrosome6,28. We now describe the molecular architecture of the
tDED-based filament complex that is formed between full-length
procaspase-8 including its catalytic domains and FADD. Char-
acterization of FADD:Caspase-8 complexes, by density gradient
centrifugation and negative-stain EM, highlights several key
observations. Firstly, the complexes are filament-like in shape
similar to the death effector filaments that have been observed
when GFP-tDEDs are expressed and visualized by confocal
microscopy7,13. In addition, the length of these filament struc-
tures is heterogeneous. Consistent with this, density gradient
centrifugation separated the complexes in order of their Caspase:
FADD ratio (i.e., low to high; Fig. 1b). Furthermore, immuno-
gold staining confirmed that the complexes are nucleated by
FADD and extend by sequential addition of multiple Caspase-8
molecules. This results in filaments of different lengths and in
cells it is therefore likely that, upon induction of extrinsic cell
death, the exact length of the complex formed will vary
depending on the local concentration of components available7,8,
with cleavage of Caspase-8 serving as a negative feedback signal
that triggers disassembly of the complex.
The complexes visualized by negative-stain EM were analyzed
using a single particle approach to establish a 3D EM map. The
initial reference-free 2D class averages revealed several notable
features. Firstly, there was less EM density in the center of each
complex, and secondly, extra EM density was observed periodi-
cally along the length of the central filament structure. We
hypothesized and confirmed this repeating extra density to be the
catalytic domains of Caspase-8 as it was absent in complexes
containing the truncated Caspase-8 tDED-only construct. Finally,
the two ends of the complex were structurally different; one
(initiating) end was closed while the other (extending) end was
open. Possibly due to heterogeneity in the length of the complexes
the highest resolution was in the center of the complex. Refine-
ment of the central region of the complex revealed that the central
tDED core of the filament was a triple helix, as recently described
when the tDEDs were expressed alone, with the published
structure (5L08;12) fitting into the EM volume as a rigid body.
The open end of the complex had the same shape as the end-view
of the refinement of the central region, suggesting this end of the
complex was open and extending. However, following FADD
nucleation, the closed end of the complex appears to be tapered
indicating that the helix does not form immediately. We, there-
fore, propose that, as implied by previous biochemical analysis of
the DISC7,8,24, a single Caspase-8 molecule initially binds to
FADD via a canonical FL motif (Type I) interaction - then sub-
sequent Caspase-8 molecules bind via both intra- and inter-
strand (Type I, Type II and Type III) interactions facilitating
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Fig. 6 c-FLIPS blocks Caspase-8 filament elongation by steric hindrance of canonical DED1 binding site. a HADDOCK modeling indicates c-FLIP DED1
pocket cannot bind Caspase-8 DED2 FL motif in the same way as Caspase-8:Caspase-8 (i), due to steric hindrance (ii), rather it binds via a predicted non-
canonical interaction motif, including other key residues (iii). b Reconstituted DISC (r-DISC: GST-TRAIL-R1 ICD:FADD:Caspase-8:c-FLIPS), assembled with WT
or mutant c-FLIPS. Data shown are from one experiment, representative of 3 independent experiments. c Structural model of the effect of the canonical versus
predicted non-canonical interaction on position of c-FLIP DED2 FL motif. d Reference-free 2D class averages generated in RELION3 of Cryo-EM analysis of
FADD:full-length Caspase-8:FLAG-c-FLIPS complexes and e 3D model refined to 13 Å in RELION3. f Refined model with published tDED-only structure (5L08;12)
fitted as a rigid body and the threaded structure of c-FLIPS orientated relative to the Caspase-8 filament via the predicted non-canonical binding motif; position
where next Caspase-8 would be recruited on the adjacent tDED strand is circled. g Structural model of how c-FLIPS binding (to green strand) blocks further
recruitment of Caspase-8 molecules to the adjacent, aligned strand (blue) within the helix. Source data are provided as a Source Data file.
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formation of the triple helix filament. Observation of thousands
of complexes by negative-stain EM, and exemplified by the
representative images in Fig. 1c, revealed that although the length
of the complexes varied (Supplementary Fig. 2), they were all of
uniform width. This suggests that all three strands of the triple
helix extend simultaneously.
In terms of structural information on the intact catalytically
inactive Caspase-8 p18-p10 monomer; our knowledge is solely
based on analysis by NMR of a truncated (ΔDED) recombinant
Caspase-8; this revealed that the inter-domain linker between the
large (p18) and small (p10) subunits blocks the active site. The
intact catalytic subunit dimer has a distinct shape (Fig. 3b;
2k7z,21), which when modeled as a rigid-body fits into the
additional EM volume we have determined to be full-length
Caspase-8 catalytic domains in the refined 3D map of the central
region of the complex. There is, however, no EM volume for the
flexible linker between the tDED domains and the p18 catalytic
subunit of Caspase-8, which is likely due to a high level of
movement in these regions of the protein. Interestingly, modeling
of these known structures into the observed EM volume revealed
the relative spatial orientation of the catalytic domains relative to
the central tDED helix filament. Based on positioning of the end
of Caspase-8 DED2 domain (S182) and initiation of the catalytic
domain (D216), it appears that the two catalytic domains making
up the active dimer belong to full-length Caspase-8 proteins on
adjacent strands within the triple helix, rather than between
Caspase-8 proteins positioned on the same strand within the
helix. Characterization of the tDED-only triple helix by Cryo-
EM12 established that within the helix, two of the strands interact
so that the DED2 domains are “aligned” to one another, whereas
the third strand interacts such that the DED2 domains are “off-
set”. In this context, we have found that the Caspase-8 catalytic
domains originate from DED2 domains on the aligned Strands 1
and 2 within the triple helix. Furthermore, the position of both
catalytic domain dimers reveals that Caspase-8 catalytic domain
interactions occur repeatedly between the same two aligned
strands (Strands 1 and 2), with each dimer being located on
different faces of the helix (Fig. 3; Supplementary Movie 1).
To further define the role of the helical arrangement of the
DED domains of full-length Caspase-8 in FADD:Caspase-8
complex assembly and subsequent Caspase-8 activation, we
focused on key interactions, both within each strand (intra-
strand; Type I) and between strands (inter-strand; Type II and
III). Mutation of all these key interactions affected the distribu-
tion of FADD:Caspase-8 complexes purified by density gradient
centrifugation and architecture of the resultant complex when
visualized by negative-stain EM (Fig. 4). The canonical F122G/
L123G (Type I) mutation predictably produced the most pro-
found effect. However, mutation of the inter-strand contacts
confirmed the importance of the overall filament structure and its
role in Caspase-8 catalytic activation and induction of cell death.
Due to the nature of the arrangement of the three tDED strands
within the helix, each inter-strand mutant makes 2 different sets
of contacts. Our data suggest that, in order to maintain Caspase-8
activity, it is the correct positioning of DED2 domains on Strand
1 and 2 that is essential to enable the p18-p10 catalytic domains
to be correctly positioned to facilitate antiparallel dimerization
and activation of Caspase-829. Mutation of K148/R149 (Type II)
directly disrupts the contact between the DED2 domains of the
aligned Strands 1 and 2. However, it also disrupts the contact
between DED2 on Strand 1 and DED1 on the offset Strand 3; a
key interaction that correctly orientates the DED2 domain on the
aligned Strand 2. Interestingly, mutating D15 on the offset Strand
3 disrupts this same stabilizing interaction between Strands 1 and
3. This further demonstrates the important role the offset Strand
3 plays within the triple helix to stabilize and maintain the correct
position of the aligned Strands 1 and 2 for catalytic dimer acti-
vation. We, therefore, have uncovered two key aspects of the
specific architecture of the tDED helix; firstly, that maintaining
the DED2 domains aligned on Strands 1 and 2 is critical for
Caspase-8 activity. Secondly, that Strand 3 has a scaffold role in
maintaining the correct helical attributes, via Type II and III
inter-strand interactions, confirming that all three types of
interactions are essential to ensure the triple helix is formed with
the correct molecular architecture. In the context of the DISC for
example, we propose that upon death receptor activation and
recruitment of the adapter protein FADD a Caspase-8 molecule is
recruited via a Type I interaction. However, in order to drive
Caspase-8 activation and cell death the triple tDED helix needs to
form and simultaneously extend all three strands; this ensures
that the catalytic domains of two Caspase-8 molecules are cor-
rectly aligned such that they are able to dimerize in an anti-
parallel orientation forming the active site.
Additional tDED proteins can be recruited into the FADD:
Caspase-8 complex and in many instances have been shown to
alter the function/activity of the complex30,31. In this study, we
have investigated the effect of c-FLIPS recruitment on the struc-
tural architecture of the complex. As with the FADD:Caspase-8
complex, we observed a broad peak following density gradient
purification, again suggesting that the FADD:Caspase-8:c-FLIPS
complex is very dynamic and highly heterogeneous. To aid ana-
lysis, we focused on a single fraction within the peak and found
by negative-stain EM that the complexes were significantly
smaller, although had a similar width to the FADD:Caspase-8
filaments characterized previously. Immuno-gold labeling
revealed that multiple Caspase-8 molecules were recruited into
each complex, whereas c-FLIPS appeared to be at one/both ends
of the complex. This is consistent with the fact that although c-
FLIPS is known to bind weakly to FADD, it is recruited primarily
via co-operative binding to Caspase-824. Taken together with the
2D class averages, these data suggest that, although a FADD:
Caspase-8 filament is initiated, when c-FLIPS is recruited to one
of the strands within the helix the filament is terminated and the
architecture of the c-FLIPS complex is altered.
While exploring the mechanism of c-FLIPS recruitment to
FADD:Caspase-8, we identified through a combination of in
silico docking and structure-guided mutagenesis a non-canonical
binding site, via which c-FLIPS DED1 interacts with Caspase-8
(Fig. 6). Computational modeling of c-FLIPS recruitment via this
site onto either of the two aligned Strands 1 or 2 of the Caspase-8
triple helix results in steric hindrance of the adjacent strand;
crucially, this would stop recruitment of additional Caspase-8
molecules to further extend the helix. Furthermore, due to the
alteration in the orientation of the FL motif on DED2 of c-FLIPS
as a result of binding via the DED1 non-canonical binding site,
no more Caspase-8 molecules can be recruited to the c-FLIPS-
containing strand of the helix. We, therefore, propose that this is
one mechanism by which c-FLIPS functions to terminate DED
filament assembly and inhibit Caspase-8 activity. It is also clear
from our data that, as a result of c-FLIPS binding and termination
of the FADD:Caspase-8 filament, the catalytic domains of the
Caspase-8 are not positioned in an active conformation as a
Caspase-8 catalytic dimer has not formed (Fig. 7; Supplementary
Movie 2). This provides a hitherto unidentified explanation to
explain the profound decrease in Caspase-8 activity observed
when c-FLIPS is recruited into the DISC24,32. The failure of
Caspase-8 catalytic domains to correctly align in the presence of
c-FLIPS is most likely due to interruption of the long-range helical
filament topology, which in turn prevents correct positioning of
Caspase-8 catalytic domains for dimerization and enzymatic
activation. Alternatively, it could be due to a non-structural
constraint such as post-translational modifications as a result of
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c-FLIPS binding, however further work would be required to
explore this.
Given that the core tDEDs of c-FLIPS and c-FLIPL are identical,
the additional DED interaction interface we have identified here
will be critically important in order to understand c-FLIPL binding
to the DED filament. This then raises the intriguing question as to
the role this non-canonical interface may play in enabling the
proposed heterodimerization of c-FLIPL pseudocaspase domain
with Caspase-8 catalytic domain; a process we and others have
shown can either stabilize or inhibit caspase-8 activity, depending
on the c-FLIPL/Caspase-8 ratio24,33–36. Importantly, in addition to
its key role in apoptosis/necroptosis, Caspase-8 has a survival role
as well as a recently reported inflammatory role that appears
dependent on its ability to oligomerize37. The profound changes in
the molecular architecture of c-FLIPS-containing complexes
reported here therefore provide insights into how incorporation of
tDED proteins, and in particular c-FLIPL/S, modulates Caspase-8
activation, thereby promoting either apoptosis (via Caspase-8:c-
FLIPL heterodimer)38–40, necroptosis (Caspase-8:c-FLIPS)40,41, or
in some settings cell survival (c-FLIP-inhibited Caspase-8 still
retains Caspase-8 ‘scaffold function’)41–46 (Fig. 8).
The model we now propose for initiation and extension of the
FADD:Caspase-8 filament is that upon nucleation of complex
formation initiated by FADD, the 3 strands within the tDED helix
extend simultaneously (Fig. 8). This mechanism provides an
additional level of regulation before a cell is committed to death.
Fig. 7 Binding of c-FLIPS prevents Caspase-8 catalytic domain dimerization. a Analysis of local resolution of 3D refined Cryo-EM map of FADD:full-length
Caspase-8:FLAG-c-FLIPS complex. b Refined map with published tDED-only structure (5L08;12) and the p18 and p10 subunits of the intact catalytic domain
dimer (modeled on NMR-based structure, 2k7z;21), fitted as a rigid body relative to the Caspase-8 filament. c EM volume of Caspase-8 DEDs, c-FLIPS (red)
and catalytic domain assembly. Each strand of the DED helix is coloured; tDEDs in blue and dark green strands are aligned, whereas tDEDs in the cyan
strand are offset. Catalytic domains are coloured gold or yellow and from their positioning within the EM map have not formed a canonical catalytic dimer.
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Fig. 8 Cryo-EM structural analysis of FADD:Caspase-8 complexes defines the catalytic dimer architecture required for co-ordinated control of cell
fate. FADD-nucleated complexes extend by sequential addition of Caspase-8 molecules, with all 3 strands within the tDED helix extending simultaneously. The
filament extends in such a way that only the catalytic domains of Caspase-8 molecules on aligned strands of the triple helix (Strand 1, blue and Strand 2, green)
are orientated correctly to enable antiparallel dimerization and full catalytic activation. The resultant catalytically active FADD:Caspase-8 complex triggers
apoptosis via several key signaling platforms, namely TNF Complex IIa, the Ripoptosome and the DISC (Death-Inducing Signaling Complex). Recruitment of the
tDED regulator, c-FLIPS, to the FADD:Caspase-8 complex significantly alters the molecular architecture of the complex and inhibits Caspase-8 enzymatic
activity via a hitherto unknown dual mechanism. A non-canonical interaction of c-FLIPS tDEDs within the helical filament alters the orientation of the aligned
strands, thus preventing recruitment of further Caspase-8 molecules to adjacent strands and causing tDED filament termination. Due to the altered topology of
the complex, the catalytic domains of Caspase-8 cannot align correctly or dimerize and therefore remain as inactive monomers. This signifies a pivotal switch in
the canonical role of Caspase-8, whereby Caspase-8 instead functions as a scaffold for complexes signaling for RIPK1/RIPK3-driven necroptosis (via the
Ripoptosome, Necrosome and TNF Complex IIb) or alternatively promotes cell survival, e.g., via the RISC (Receptor-Induced Signaling Complex).
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The requirement for recruitment of a minimum number of
Caspase-8 molecules to ensure two Caspase-8 catalytic domains
are correctly orientated to support antiparallel activation, pre-
vents aberrant Caspase-8 activation. Once the filament has
achieved the minimum length, the catalytic domains on the
aligned Strands 1 and 2 of the triple helix are able to dimerize and
become activated. By contrast, recruitment of c-FLIPS to the
FADD:Caspase-8 complex significantly alters the molecular
architecture of the complex. Importantly, we identify that the
interaction pocket of c-FLIPS DED1 into which the FL motif of
Caspase-8 DED2 binds includes additional interaction residues.
This non-canonical interaction interface in c-FLIPS DED1 alters
the orientation of c-FLIPS tDEDs within the helical filament.
Consequently, c-FLIPS functions to inhibit Caspase-8 activity by
at least two mechanisms; first, by preventing recruitment of
Caspase-8 molecules to adjacent strands of the helical filament
thereby causing filament termination and second, by altering the
topology of the complex thereby preventing dimerization of
Caspase-8 catalytic domains. These profound changes in the
molecular architecture of c-FLIPS-containing complexes not only
provide insights to explain c-FLIP regulation of FADD:Caspase-8,
but also how the incorporation of other tDED proteins could
result in similarly significant changes to the architecture and
signaling output of FADD:Caspase-8 complexes involved in the
determination of cell fate. Crucially, since efforts are currently
underway to target c-FLIPL/S therapeutically using small molecule
inhibitors, our findings also provide the molecular basis for tar-
geting previously unidentified structural interactions.
Methods
Materials. Media and serum were purchased from Invitrogen (Paisley, UK).
Antibodies were sourced as follows: FADD mouse monoclonal antibody (mAb)
(610400, 1:500) was from BD Transduction Laboratories; Myc mouse mAb (2276,
1:1000) was from Cell Signaling; Caspase-8, p18-specific mouse mAb (AG-20B-
0057-C050, 1:500) and c-FLIP mouse mAb (AG-20B-0056-C050, 1:500) were from
Adipogen Corp. Caspase-8, N-terminal specific mouse mAb (04-574, 1:500) was
from Millipore. Caspase-10 mouse mAb (M059-3, 1:1000) was from MBL. Vin-
culin mouse mAb (ab130007, 1:1000) was from Abcam. Anti-FLAG M2 mouse
mAb (F3165, 1:1000) was from Sigma Aldrich. HRP-conjugated goat anti-mouse
secondary antibody (A8924, 1:2000) was from Sigma Aldrich and HRP-conjugated
goat anti-rabbit secondary antibody (P0448, 1:2000) was from DAKO. The
Caspase-8 substrate, Ac-Ile-Glu-Thr-Asp-amino-4-trifluoromethyl coumarin (Ac-
IETD.AFC) was from MP Biomedicals. All other chemicals were of analytical grade
and obtained from Sigma-Aldrich or Fisher.
Expression constructs. Full-length FADD, Caspase-8 and c-FLIPS were cloned
into pcDNA3 vectors with or without a non-cleavable 1xFLAG Tag. The constructs
were co-transfected into HEK293F cells with polyethylenimine (PEI; Sigma) and
harvested after 16 h47. GST-TRAIL-R1/R2-IcD and CD95-IcD were cloned into
pGEX4T (GE Healthcare) and their respective fusion proteins produced in E
coli2,48. Full-length FADD was cloned into the vector pTYB1 (NEB Inc.) and
recombinant FADD (r-FADD) generated in E coli19. Full-length procaspase-8b
(MACHα2/Mch5b) was cloned in pcDNA3.1 (Invitrogen) and untagged proteins
produced by in vitro transcription/translation (IVT) (Insect System; Qiagen),
incorporating 35S-methionine (GE Healthcare)19. Mutations were made using the
Stratagene QuikChange Site-Directed Mutagenesis kit and confirmed by DNA
sequencing. Proteins from c-FLIPS·Myc in pcDNA6.1 were produced by IVT (TNT
T7-coupled reticulocyte lysate system; Promega).
Cell culture. Adherent HEK293H and suspension HEK293F cells (both from
Invitrogen), were maintained in FreeStyle 293 F or DMEM medium, supplemented
with 10% fetal bovine serum (FBS). Cells were grown in an atmosphere of 10% CO2
in air at 37 °C (for 293F cells, shaking at 120 rpm) and maintained in logarithmic
growth phase by routine passage every 3–4 days. Caspase-8-deficient Jurkat T cells
(gift from J Blenis) were cultured in RMPI media, supplemented with 10% FBS and
2mM Glutamax, and maintained in 5% CO2 at 37 °C.
Generation of CRISPR/Cas9 Caspase-8-null 293F cells. Caspase-8-deficient
293F cells were generated using the CRISPR-Cas9 system. 293H cells were tran-
siently transfected using Lipofectamine™ 3000 Transfection Reagent (Thermo
Fischer Scientific, Waltham, MA, USA) according to manufacturer’s instructions.
gRNAs were inserted into the all-in-one guide RNA/Cas9 expression vector,
pLEIC-97 (Protein Expression Laboratory (PROTEX), University of Leicester).
gRNA sequences (Supplementary Table 2) were used as described in49 to target the
5’ end of the gene, and thus all isoforms of Caspase-8. One-day post-transfection,
puromycin was added for two days to select for transfected cells. Single clones were
isolated, analyzed for successful Caspase-8 knockout and adapted for suspension
culture.
DISC reconstitution. Complete reconstitutions were carried out as described19.
Briefly, glutathione sepharose beads coated with purified GST-CD95-IcD or GST-
TRAIL-R1/R2-IcD (10 µg)2,48 were incubated with recombinant FADD (r-FADD;
5 µg), and the indicated amounts of IVT-produced wild-type or mutant
procaspase-8b (35S-labeled) for 16 h at 20 °C. Control reconstitutions contained
glutathione sepharose beads coated with GST-alone. Bead-associated complexes
were analyzed by SDS-PAGE/Western blotting. Reconstituted DISC-associated
Caspase-8 cleavage activity was measured using the fluorogenic substrate Ac-IETD.
AFC (40 µM) at 37 °C on a Victor X4 fluorimeter.
Western blot analysis. Proteins were resolved by SDS-PAGE using the Mini-
Protean III or Criterion TGX Precast gel systems (Biorad Laboratories) and
transferred to ‘Hypond C Extra’ nitrocellulose membrane (GE Healthcare) using
the Mini-Trans Blot system (Biorad Laboratories). Blots were then probed with the
indicated primary antibodies, followed by the appropriate HRP-conjugated sec-
ondary antibody. Immunolabelled proteins were visualized using ECL enhanced
chemiluminescence (GE Healthcare) according to the manufacturer’s instructions.
Transient co-transfection of Caspase-8 mutants with GFP and analysis of cell
death. For co-transfection of catalytically active Caspase-8 wild-type or Type I/II/
III mutants with GFP, Caspase-8-deficient Jurkat cells were plated 24 h prior to
transfection with a 5:1 ratio of Caspase-8: EGFP, using PEI (Sigma). 24 h post-
transfection, cells were treated with or without ant-CD95 (clone CH11; Cell Sig-
naling) for 4 h and cell death measured by FACS analysis. By using EGFP as a
transfection marker, cell death in transfected cells was specifically quantified on a
BD FACSCanto II flow cytometer using Annexin V-APC (Cambridge Bioscience)
and Draq 7 co-labeling and gating of GFP-positive cells only. Data were analyzed
using BD FACS Diva v8.0.01; Annexin V labeling was used as a marker of early
apoptotic cells, double-labeled Annexin V/Draq 7 cells represented late apoptotic
cells and double-negative cells represented viable cells. Graphical representation of
FACS sequential gating strategy is provided in Supplementary Fig. 21.
Quantitative mass spectrometry. LC-MS/MS was used to quantify the proteins
present in the purified FADD-nucleated Caspase-8 complexes. Purified protein
complexes were separated using 30–70% glycerol density gradients. Proteins in
each gradient fraction were precipitated using the UPPA protein precipitation kit
(gBioscience) according to the manufacturer’s Instructions. The precipitated pro-
teins were re-suspended and then digested with trypsin. Extracted tryptic peptides
were concentrated to dryness and re-suspended in 5% formic acid (FA) and
acetonitrile (9:1), spiked with 20–40 fmol/µl ADH1 and BSA MassPREP standards
(Waters Corporation, Manchester, UK). Aliquots (2–4 µl) were applied to a
reverse-phase BEH130 C18 column (25 cm × 75 µm × 1.7 µm I.D.) using a Waters
nanoAcquity UPLC system interfaced to a Synapt G2-S HDMS mass spectrometer.
Peptides were eluted (0.3 µl/min) with 50 min, 3–40 % (0.1% FA/acetonitrile)
gradients and analyzed in data-independent acquisition (DIA) and ion mobility
(HDMSE) modes using a T-wave velocity of 650 m/s50. Stepped 4 eV and 20–50 eV
voltage switching generated collision induced (CID) peptide fragmentation. Low
energy and CID LC-MS/MS data were acquired (1 s cycle scan time and 50–2000
m/z mass range) and processed using Waters ProteinLynx Global SERVER (PLGS
3.0) using the UniProt Human database (UniProtKB release 2014_11, 20,265
entries). Peptide mass and fragment mass tolerances were set to auto, with one
missed cleavage and variable modifications for methionine oxidation and carba-
midomethylation of cysteines. The PLGS “TOP 3” method with a false discovery
rate of 1% was used for absolute protein quantification24,51.
Preparation of FADD:Caspase-8 and FADD:Caspase-8:c-FLIPS complexes.
Caspase-8 (C360A) and FLAG-FADD or Caspase-8 (C360A), FADD and FLAG-c-
FLIPS were co-expressed in Caspase-8-deficient HEK 293F cells and purified using
FLAG-affinity beads followed by 30–70% glycerol density gradient purification.
Single fractions from the glycerol gradients (centrifuged using SW60Ti rotor
125,812 × g at 4 °C for 17 h) were analyzed by Western blotting and negative stain
and/or Cryo-electron microscopy.
Grid preparation for negative-stain and cryo-electron microscopy. Purified
protein complexes were chemically fixed and the glycerol concentration diluted by
mixing gradient fraction with equi-volumes of 2% (negative stain) or 0.1% (Cryo)
glutaraldehyde in 150 mM NaCl, 20 mM HEPES-KOH (pH7.4) buffer. Negative
staining was carried out according to conventional procedures. Briefly, a small
amount (3 µl) of the sample was loaded onto carbon-coated grids (300 mesh gold,
EM resolutions Ltd, Sheffield UK), which had been glow-discharged for 30–60 s at
30 mA using a GloQube instrument (Quorum Technologies Ltd., East Sussex UK).
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After incubation at 5 °C overnight, the excess volume was removed by blotting with
filter paper. Grids were stained with two drops of 2.5 % (w/v) uranyl acetate
solution for 60 s, which was filtered to remove aggregates and then blotted with
filter paper to stop the staining and dry the grids. Anti-capillary self-crossover
tweezers (N5AC, Dumont, Montignez Switzerland) were used for all procedures.
For Cryo-EM, 3 µl fixed sample was applied to glow-discharged Quantifoil R1.2/1.3
gold mesh (Quantifoil Micro Tools GmbH, Germany) graphene oxide (Sigma-
Aldrich)-coated holey carbon grids. After incubation for 1 min, excess volume was
blotted with filter paper and sample-loading repeated 3X times prior to plunge-
freezing using a Vitrobot (FEI).
Immunogold-labeling of complexes. For immunogold-labeling of purified com-
plexes, the samples were adsorbed on to the carbon-coated grids (300 mesh size,
Gold). Protein samples were blocked with 2% or 0.2% BSA in HEPES buffer for 30
min at room temperature and specific proteins within the complexes were then
labeled by incubating with anti-caspase-8 C15 mouse mAb (AG-20B-0056-C050,
1:100; Adipogen Corp.), anti-FLAG rabbit polyclonal (F7425, 1:100; Sigma-
Aldrich), or anti-FLAG M2 mouse mAb (F3165, 1:100; Sigma-Aldrich) in 0.2 %
BSA HEPES buffer for 2 h at RT in a moisture chamber. After washing with three
drops of 0.2 % BSA-HEPES buffer, the grids were incubated with 5 nm or 10 nm
gold-conjugates with anti-IgG antibody (EM.GAR5/10, EM.GAF5 or EM.
GMHL10, 1:20; BBI Solutions, Newport UK) or protein-G (AC-5-18-05, 1:20;
Cytodiagnostics Inc., ON Canada) in 0.2 % BSA HEPES buffer for 2 h at RT. After
washing with 3 drops of HEPES buffer, specimens were stained with uranyl acetate.
Negative-stain EM data collection and image processing. Negative stain TEM
data were collected on well-dried specimens using a Talos electron microscope
(FEI), operated at 200 kV acceleration. Images were recorded using the EPU system
(Thermo Fisher Scientific, MA USA) at room temperature using a 4096 × 4096
pixel CMOS camera Ceta16M (FEI), at a magnification of x 57,000 (pixel size
1.83 Å), 1 s exposure per micrograph. FLAG-FADD complexes were manually
picked from 620 micrographs yielding a dataset of 3200 particles, as summarized in
Supplementary Table 1. The single-particle analysis was then performed using
RELION27,52 and initial models generated and refined in CryoSPARC53, as sum-
marized in Supplementary Figs. 4, and 7.
Cryo-EM data collection and image processing. Cryo-EM data optimization and
screening was performed on a Talos (200 kV using a Falcon 2 direct electron
detector). Cryo-EM data collection was performed on a Titan Krios electron
microscope (FEI) operated at an acceleration voltage of 300 kV using a Falcon 3
direct electron detector camera (FEI). Images were recorded with a pixel size of
1.08 Å, 1 s exposures at 93 electrons/Å2/sec dose rate, 39 fractions. A total of 534
images were used for analysis and processing. Motioncorr 2 was used for motion
correction54 and GCTF was used for CTF estimation as implemented in RELION
3. FLAG-c-FLIPS:FADD:Caspase-8 complexes were initially picked using
CrYOLO26, yielding a dataset of 12918 particles. Reference-free 2D Class averages
were generated from these data in RELION 3 and 10 good classes then used as
templates for auto-picking of particles in RELION 3, yielding a dataset of 46023
particles (Supplementary Table 1). The single-particle analysis was performed in
RELION 327, as outlined in the flowchart in Supplementary Fig. 17, resulting in a
final post-processed EM map with a final resolution of ~13 Å.
Atomic structure fitting. Docking was done using published structures; the Cryo-
EM structure of Caspase-8 tDED filament (5L08;12), and the NMR structure of
monomeric un-cleaved Caspase-8 catalytic domain (2k7z;21). A homology model
of c-FLIPS, obtained using Phyre255 was used for fitting into the FLAG-c-FLIPS:
FADD:Caspase-8 reconstruction. Structures were automatically fitted as rigid-
bodies into the generated EM maps using the UCSF Chimera package56.
HADDOCK docking. HADDOCK 2.0 High Ambiguity Driven protein-protein
DOCKing57, developed by Dominguez et al.58, was used for docking of c-FLIPS
DED1 with Caspase-8 DED2 as it enabled the use of experimental mutagenesis
data to drive the sampling around the contact regions of the interacting proteins by
introducing interaction restraints. This enabled new residues involved in the
binding interface to be identified (Supplementary Fig. 16).
Statistics and reproducibility. The number of independent experiments and of
replicates (n) is indicated in the figure legends. All the Western blotting
and micrograph data were repeated independently three times with similar
results. Statistical analysis was performed using Prism 7 or 8 software
(GraphPad).
Reporting summary. Further information on research design is available in the Nature
Research Reporting Summary linked to this article.
Data availability
Data supporting the findings of this manuscript are available from the corresponding
authors upon reasonable request. A reporting summary for this Article is available as
a Supplementary Information file.
Source data are provided with this paper.





The mass spectrometry proteomics data have been deposited to the ProteomeXchange
Consortium via the PRIDE partner repository (http://www.ebi.ac.uk/pride) with the dataset
identifier PXD022408 and 10.6019/PXD022408. Source data are provided with this paper.
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